|

Mid-afternoon market update: Nasdaq rises 50 points, Jefferies shares drop

Toward the end of trading Wednesday, the Dow traded up 0.05% to 36,269.24 while the NASDAQ rose 0.35% to 15,205.90. The S&P also rose, gaining, 0.26% to 4,725.52.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 63,390,870 cases with around 863,890 deaths. India confirmed a total of at least 36,070,510 cases and 484,650 deaths, while Brazil reported over 22,630,140 COVID-19 cases with 620,280 deaths. In total, there were at least 314,292,710 cases of COVID-19 worldwide with more than 5,522,840 deaths.

Leading and Lagging Sectors

Information technology shares rose 0.6% on Wednesday. Meanwhile, top gainers in the sector included Ebix, Inc. EBIX +15.26% (Get Free Alerts for EBIX), up 14% and Innodata Inc. INOD +9.47% (Get Free Alerts for INOD) up 9%.

In trading on Wednesday, health care shares fell by 0.4%.

Top Headline

The annual inflation rate in the US increased to 7% in December, notching a fresh high since June 1982, and up from 6.8% in the previous month. Analysts, however, were expecting a 7% inflation rate. The CPI rose 0.50% month-over-month during December.

Equities Trading UP

Immix Biopharma, Inc. IMMX +18.42% shares shot up 26% to $6.83 after the company announced preclinical data of its lead program, IMX-110. The data showed that IMX-110 produced a 50% response rate in first-line-therapy-resistant cancer - soft tissue sarcoma (STS) mouse study, surpassing the STS standard of care doxorubicin’s 0% response rate in the same mouse study.

Shares of Fresh Vine Wine, Inc. VINE +19.24% got a boost, shooting 44% to $8.41 after the company reported a partnership with CRAVE American Kitchen & Sushi Bar.

Immuron Limited IMRN +46.18% shares were also up, gaining 43% to $3.65. Immuron received funding of A$6.2 ($4.45) million from the U.S Department of Defense to examine a dosing regimen for Travelan more suited for use by the military.

Equities Trading DOWN

Koninklijke Philips N.V. PHG -14.68% shares tumbled 15% to $32.77 after the company provided an update on its financial performance in Q4 2021. Philips hiked the cost of its recall of ventilators and warned earnings would take a big hit from global supply chain shortages.

Shares of Jefferies Financial Group Inc. JEF -9.29% were down 11% to $36.86 after the company reported worse-than-expected Q4 sales results.

Aclaris Therapeutics, Inc. ACRS -13.61% was down, falling 14% to $11.04. Providing a R&D update, Aclaris Therapeutics said David Gordon, its chief medical officer left the company, effective Jan. 7. The company also announced update on its two Phase 2 programs that evaluate zunsemetinib in subjects with moderate to severe rheumatoid arthritis and in subjects with moderate to severe hidradenitis suppurative.

Commodities

In commodity news, oil traded up 2% to $82.83, while gold traded up 0.3% to $1,824.20.

Silver traded up 1.5% Wednesday to $23.155 while copper rose 3.8% to $4.5990.

Euro zone

European shares closed higher today. The eurozone’s STOXX 600 gained 0.65%, London’s FTSE 100 rose 0.71%, while Spain’s IBEX 35 Index rose 0.16%. The German DAX gained 0.43%, French CAC 40 climbed 0.75% and Italy’s FTSE MIB Index gained 0.65%.

Wholesale price inflation in Germany slowed to 16.1% in December from a record level of 16.6% in the previous month.

Economics

The annual inflation rate in the US increased to 7% in December, notching a fresh high since June 1982, and up from 6.8% in the previous month. Analysts, however, were expecting a 7% inflation rate. The CPI rose 0.50% month-over-month during December.

US crude-oil inventories dropped 4.6 million barrels last week, the EIA said.

The Federal Open Market Committee released its Beige Book report.

Author

Benzinga Team

Benzinga's news desk is a dynamic and innovative team that provides real-time, actionable articles that help readers navigate the market.

More from Benzinga Team
Share:

Editor's Picks

EUR/USD makes a U-turn, focus on 1.1900

EUR/USD’s recovery picks up further pace, prompting the pair to retarget the key 1.1900 barrier amid further loss of momentum in the US Dollar on Wednesday. Moving forward, investors are expected to remain focused on upcoming labour market figures and the always relevant US CPI prints on Thursday and Friday, respectively.

GBP/USD sticks to the bullish tone near 1.3660

GBP/USD maintains its solid performance on Wednesday, hovering around the 1.3660 zone as the Greenback surrenders its post-NFP bounce. Cable, in the meantime, should now shift its attention to key UK data due on Thursday, including preliminary GDP gauges.

Gold holds on to higher ground ahead of the next catalyst

Gold keeps the bid tone well in place on Wednesday, retargeting the $5,100 zone per troy ounce on the back of modest losses in the US Dollar and despite firm US Treasury yields across the curve. Moving forward, the yellow metal’s next test will come from the release of US CPI figures on Friday.

Ripple Price Forecast: XRP sell-side pressure intensifies despite surge in addresses transacting on-chain 

Ripple (XRP) is edging lower around $1.36 at the time of writing on Wednesday, weighed down by low retail interest and macroeconomic uncertainty, which is accelerating risk-off sentiment.

US jobs data surprises to the upside, boosts stocks but pushes back Fed rate cut expectations

This was an unusual payrolls report for two reasons. Firstly, because it was released on  Wednesday, and secondly, because it included the 2025 revisions alongside the January NFP figure.

XRP sell-off deepens amid weak retail interest, risk-off sentiment

Ripple (XRP) is edging lower around $1.36 at the time of writing on Wednesday, weighed down by low retail interest and macroeconomic uncertainty, which is accelerating risk-off sentiment.